Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial - Khalaf, D J; Annala, M; Taavitsainen, S (Lancet Oncol, 2019)
et al.